High in-plane resolution T2-weighted magnetic resonance Imaging of acute myocardial ischemia in pigs using the intravascular contrast agent NC100150 injection

被引:18
作者
Bjerner, T [1 ]
Wikström, G
Johansson, L
Ahlström, H
机构
[1] Univ Uppsala Hosp, Dept Radiol, S-75185 Uppsala, Sweden
[2] Univ Uppsala Hosp, Dept Cardiol, S-75185 Uppsala, Sweden
[3] Amersham Hlth, Oslo, Norway
关键词
cardiac MRI; intravascular contrast agents; iron oxide particles; myocardial perfusion; animal study;
D O I
10.1097/01.rli.0000129153.64225.7f
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Rationale and Objectives: The intravascular contrast agent NC100150 injection was tested for its ability to demarcate nonperfused myocardium in a porcine model of coronary occlusion. Materials and Methods: A T2-weighted fast spin echo sequence was acquired ex vivo and in vivo during first pass and steady-state circulation of the contrast agent in 2 dosages (2 and 5 mg Fe/kg bw) or saline. Results: Ex vivo, in the high-dose group, the volume of nonperfused myocardium determined from T2-weighted images was 99% of that determined from photographs where perfused myocardium stained with fluorescein. A significantly higher contrast to noise ratio between perfused and nonperfused myocardium was found (both ex and in vivo in steady state) compared with the control group. During first pass, a significant reduction in signal intensity (74 +/- 18%) was found in perfused myocardium after contrast injection. Conclusion: NC100150 injection, combined with T2-weighted turbo spin echo imaging, allowed detailed visualization of nonperfused myocardium in the steady state, which corresponded to the area at risk as determined by fluorescein.
引用
收藏
页码:470 / 478
页数:9
相关论文
共 30 条
[1]  
Bjerner T, 2000, J MAGN RESON IMAGING, V12, P866, DOI 10.1002/1522-2586(200012)12:6<866::AID-JMRI9>3.0.CO
[2]  
2-Q
[3]   First-pass myocardial perfusion MR imaging with outer-volume suppression and the intravascular contrast agent NC1001150 injection:: Preliminary results in eight patients [J].
Bjerner, T ;
Johansson, L ;
Ericsson, A ;
Wilkström, G ;
Hemmingsson, A ;
Ahlström, H .
RADIOLOGY, 2001, 221 (03) :822-826
[4]  
Bjornerud A, 2000, MAGNET RESON MED, V44, P803, DOI 10.1002/1522-2594(200011)44:5<803::AID-MRM19>3.0.CO
[5]  
2-K
[6]   Assessment of T1 and T*2 effects in vivo and ex vivo using iron oxide nanoparticles in steady state-dependence on blood volume and water exchange [J].
Bjornerud, A ;
Johansson, LO ;
Briley-Sæbo, K ;
Ahlström, HK .
MAGNETIC RESONANCE IN MEDICINE, 2002, 47 (03) :461-471
[7]   RATIONALE AND APPLICATIONS FOR MACROMOLECULAR GD-BASED CONTRAST AGENTS [J].
BRASCH, RC .
MAGNETIC RESONANCE IN MEDICINE, 1991, 22 (02) :282-287
[8]  
Brasch RC, 1991, MAGN RESON MED, V22
[9]   Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart - A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association [J].
Cerqueira, MD ;
Weissman, NJ ;
Dilsizian, V ;
Jacobs, AK ;
Kaul, S ;
Laskey, WK ;
Pennell, DJ ;
Rumberger, JA ;
Ryan, T ;
Verani, MS .
CIRCULATION, 2002, 105 (04) :539-542
[10]  
Chapon C, 2003, INVEST RADIOL, V38, P141